Epidemiological and Clinical Characteristics of Deceased COVID-19 Patients

References

• World Health Organization (WHO). Coronavirus Disease (COVID-19): Weekly Epidemiological Update. Geneva: WHO; 2020.
   Google Scholar
• Ministry of Health (MOH). Coronavirus Disease (COVID-19): Daily Report Update. Riyadh: MOH; 2020.
   Google Scholar
• Badedi M, Makrami A, Alnami A. Co-morbidity and blood group type risk in coronavirus disease 2019 patients: a case–control study. J Infect Public Health. 2021;14(4):550–554. doi:10.1016/j.jiph.2020.12.035
   PubMed Web of Science ®Google Scholar
• Bai Y, Yao L, Wei T, et al. Presumed asymptomatic carrier transmission of COVID-19. JAMA. 2020;323(14):1406–1407. doi:10.1001/jama.2020.2565
   PubMed Web of Science ®Google Scholar
• Ye F, Xu S, Rong Z, et al. Delivery of infection from asymptomatic carriers of COVID–19 in a familial cluster. Int J Infect Dis. 2020;94:133–138. doi:10.1016/j.ijid.2020.03.042
   PubMed Web of Science ®Google Scholar
• Verity R, Okell L, Dorigatti I, et al. Estimates of the severity of coronavirus disease 2019: a model–based analysis. Lancet Infect Dis. 2020;20:669–677. doi:10.1016/S1473-3099(20)30243-7
   PubMed Web of Science ®Google Scholar
• Yuki K, Fujiogi M, Koutsogiannaki S. COVID–19 pathophysiology: a review. Clin Immunol. 2020;215:108427. doi:10.1016/j.clim.2020.108427
   PubMed Web of Science ®Google Scholar
• Zhang B, Zhou X, Qiu Y, et al. Clinical characteristics of 82 cases of death from COVID-19. PLoS One. 2020;15(7):e0235458. doi:10.1371/journal.pone.0235458
   PubMed Web of Science ®Google Scholar
• Panthee B, Dhungana S, Panthee N, Gyawali S, Paudel A, Panthee S. Clinical and epidemiological features of COVID-19 deaths in Nepal. New Microbes New Infect. 2020;38:100797. doi:10.1016/j.nmni.2020.100797
   PubMed Web of Science ®Google Scholar
• Badedi M, Darraj H, Hummadi A, et al. Khat chewing and type 2 diabetes mellitus. Diabetes Metab Syndr Obes. 2020;13:307–312.
   PubMed Web of Science ®Google Scholar
• Alzughbi T, Badedi M, Darraj H, et al. Diabetes-related distress and depression in Saudis with type 2 diabetes. Psychol Res Behav Manag. 2020;13:453–458. doi:10.2147/PRBM.S255631
   PubMed Web of Science ®Google Scholar
• Badedi M, Darraj H, Hummadi A, et al. Vitamin B12 deficiency and foot ulcers in type 2 diabetes mellitus: a Case-Control Study. Diabetes Metab Syndr Obes. 2019;12:2589–2596. doi:10.2147/DMSO.S233683
   PubMed Web of Science ®Google Scholar
• Rees E, Nightingale E, Jafari Y, et al. COVID-19 length of hospital stay: a systematic review and data synthesis. BMC Med. 2020;18(1):270. doi:10.1186/s12916-020-01726-3
   PubMed Web of Science ®Google Scholar
• World Health Organization (WHO). Physical status: the use and interpretation of anthropometry: report of a WHO expert committee. Technical report series 854. Geneva: WHO; 1995.
   Google Scholar
• BM Corp. IBM SPSS Statistics for Windows. NY: IBM Corp; 2012.
   Google Scholar
• Wang D, Hu B, Hu C, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA. 2020;323(11):1061–1069. doi:10.1001/jama.2020.1585
   PubMed Web of Science ®Google Scholar
• Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395:1054–1062. doi:10.1016/S0140-6736(20)30566-3
   PubMed Web of Science ®Google Scholar
• Goronzy J, Fang F, Cavanagh M, Qi Q, Weyand C. Naive T cell maintenance and function in human aging. J Immunol. 2015;194(9):4073–4080. doi:10.4049/jimmunol.1500046
   PubMed Web of Science ®Google Scholar
• Opal S, Girard T, Ely E. The immunopathogenesis of sepsis in elderly patients. Clin Infect Dis. 2005;41(Supplement 7):504–512. doi:10.1086/432007
   PubMed Web of Science ®Google Scholar
• Wu B, Gu D, Yu J, Yang J, Shen W. Association between ABO blood groups and COVID-19 infection, severity and demise: a systematic review and meta-analysis. Infect Genet Evol. 2020;84:104485. doi:10.1016/j.meegid.2020.104485
   PubMed Web of Science ®Google Scholar
• Li W, Moore M, Vasilieva N, et al. Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature. 2003;426(6965):450–454. doi:10.1038/nature02145
   PubMed Web of Science ®Google Scholar
• Xu Z, Shi L, Wang Y, et al. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med. 2020;8(4):420–422. doi:10.1016/S2213-2600(20)30076-X
   PubMed Web of Science ®Google Scholar
• Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497–506. doi:10.1016/S0140-6736(20)30183-5
   PubMed Web of Science ®Google Scholar
• Xu X, Wu X, Jiang X, et al. Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series. BMJ. 2020;368:m606. doi:10.1136/bmj.m606
   PubMed Web of Science ®Google Scholar
• Tan L, Wang Q, Zhang D, et al. Lymphopenia predicts disease severity of COVID–19: a Descriptive and Predictive Study. Signal Transduct Target Ther. 2020;5:33. doi:10.1038/s41392-020-0148-4
   PubMed Web of Science ®Google Scholar
• Li H, Xiang X, Ren H, et al. Serum amyloid A is a biomarker of severe coronavirus disease and poor prognosis. J Infect. 2020;80:646–655. doi:10.1016/j.jinf.2020.03.035
   PubMed Web of Science ®Google Scholar
• Lin L, Lu L, Cao W, Li T. Hypothesis for potential pathogenesis of SARS–CoV–2 infection–a review of immune changes in patients with viral pneumonia. Emerg Microbes Infect. 2020;9:727–732. doi:10.1080/22221751.2020.1746199
   PubMed Web of Science ®Google Scholar
• Yao Z, DuBois D, Almon R, Jusko W. Pharmacokinetic/pharmacodynamic modeling of corticosterone suppression and lymphocytopenia by methylprednisolone in rats. J Pharm Sci. 2008;97:2820–2832. doi:10.1002/jps.21167
   PubMed Web of Science ®Google Scholar
• Chen G, Wu D, Guo W, et al. Clinical and immunological features of severe and moderate coronavirus disease 2019. J Clin Investig. 2020;130:2620–2629. doi:10.1172/JCI137244
   PubMed Web of Science ®Google Scholar
• Liu J, Li S, Liu J, et al. Longitudinal characteristics of lymphocyte responses and cytokine profiles in the peripheral blood of SARS–CoV–2 infected patients. EBioMedicine. 2020;55:102763. doi:10.1016/j.ebiom.2020.102763
   PubMed Web of Science ®Google Scholar
• Liu J, Liu Y, Xiang P, et al. Neutrophil–to–lymphocyte ratio predicts critical illness patients with 2019 coronavirus disease in the early stage. J Transl Med. 2020;18:206. doi:10.1186/s12967-020-02374-0
   PubMed Web of Science ®Google Scholar
• Lippi G, Mattiuzzi C. Hemoglobin value may be decreased in patients with severe coronavirus disease 2019. Hematol Transfus Cell Ther. 2020;42:116–117. doi:10.1016/j.htct.2020.03.001
   PubMedGoogle Scholar
• Northrop–Clewes C. Interpreting indicators of iron status during an acute phase response––lessons from malaria and human immunodeficiency virus. Ann Clin Biochem. 2008;45:18–32. doi:10.1258/acb.2007.007167
   PubMed Web of Science ®Google Scholar
• Lippi G, Favaloro E. D–dimer is associated with severity of coronavirus disease 2019: a pooled analysis. Thromb Haemost. 2020;120:876–878. doi:10.1055/s-0040-1709650
   PubMed Web of Science ®Google Scholar
• Han H, Yang L, Liu R, et al. Prominent changes in blood coagulation of patients with SARS–CoV–2 infection. Clin Chem Lab Med. 2020;58:1116–1120. doi:10.1515/cclm-2020-0188
   PubMed Web of Science ®Google Scholar
• Tang N, Li D, Wang X, Sun Z. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J Thromb Haemost. 2020;18:844–847. doi:10.1111/jth.14768
   PubMed Web of Science ®Google Scholar
• Wang Z, Yang B, Li Q, Wen L, Zhang R. Clinical features of 69 cases with coronavirus disease 2019 in Wuhan, China. Clin Infect Dis. 2020. doi:10.1093/cid/ciaa538
   Web of Science ®Google Scholar
• Cai Q, Huang D, Ou P, et al. COVID-19 in a designated infectious diseases hospital outside Hubei Province, China. Allergy. 2020;75(7):1742–1752. doi:10.1111/all.14309
   PubMed Web of Science ®Google Scholar
• Longo M, Caruso P, Maiorino M, Bellastella G, Giugliano D, Esposito K. Treating type 2 diabetes in COVID-19 patients: the potential benefits of injective therapies. Cardiovasc Diabetol. 2020;19(1):115. doi:10.1186/s12933-020-01090-9
   PubMed Web of Science ®Google Scholar